Allogene Therapeutics, Inc. ALLO
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-10-11
Chart by TradingView
2/9
Piotroski F — financial health
-13.1
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $0 | $22,000 | $95,000 | $156,000 | $114.1M |
| Operating income | -$209.3M | -$273.2M | -$327.7M | -$335.5M | -$180.2M |
| Net income | -$190.9M | -$257.6M | -$327.3M | -$340.4M | -$182.1M |
| Operating cash flow | -$149.2M | -$200.3M | -$237.7M | -$220.5M | -$184.8M |
| Free cash flow | -$149.6M | -$201.0M | -$239.2M | -$225.7M | -$206.3M |
| Total assets | $415.9M | $548.7M | $642.8M | $821.6M | $1.0B |
| Total liabilities | $123.4M | $126.5M | $130.6M | $154.7M | $122.2M |
| Shareholders' equity | $292.5M | $422.2M | $512.2M | $666.9M | $925.2M |
| Ratios | |||||
| Operating margin | — | -1241813.6% | -344986.3% | -215087.2% | -157.9% |
| Net margin | — | -1170863.6% | -344489.5% | -218214.1% | -159.6% |
| FCF margin | — | -913609.1% | -251841.1% | -144685.9% | -180.8% |
| Return on assets | -45.9% | -46.9% | -50.9% | -41.4% | -17.5% |
| Return on equity | -65.3% | -61.0% | -63.9% | -51.0% | -19.7% |
| Current ratio | 7.93 | 8.54 | 12.38 | 9.84 | 9.78 |
| Revenue growth | -100.0% | -76.8% | -39.1% | -99.9% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 2,139,328 | $5.2M |
| Point72 Asset Management, L.P. | 221,335 | $540,057 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -13.1 (distress)
- Working capital / assets 0.542
- Retained earnings / assets -4.835
- EBIT / assets -0.503
- Equity / liabilities 2.371
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001737287 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.